Cita APA

Motta-Guerrero, R., Recondo, G., Cardona, A., Corrales, L., Arnao, V., Failoc-Rojas, V., & Aliaga, C. (2024). The role of angiogenesis inhibitors associated with tyrosine kinase inhibitors in the first-line treatment for EGFR-mutated advanced lung cancer.

Citación estilo Chicago

Motta-Guerrero, R., G. Recondo, A. Cardona, L. Corrales, V. Arnao, VE Failoc-Rojas, y C. Aliaga. The Role of Angiogenesis Inhibitors Associated With Tyrosine Kinase Inhibitors in the First-line Treatment for EGFR-mutated Advanced Lung Cancer. 2024.

Cita MLA

Motta-Guerrero, R., et al. The Role of Angiogenesis Inhibitors Associated With Tyrosine Kinase Inhibitors in the First-line Treatment for EGFR-mutated Advanced Lung Cancer. 2024.